Ypsomed Holding AG
SIX: YPSN.SW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Swiss Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Simon Michel
- Employees
- 2,600
- Headquarters
- Burgdorf, Switzerland
- IPO year
- 2004
- Market cap
- CHF 3.9B
- Website
- https://www.ypsomed.com
Loading YPSN…
Loading profile data…Frequently asked questions about YPSN
What does Ypsomed Holding AG (YPSN.SW) do?
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injecto...
Where does YPSN.SW trade?
Ypsomed Holding AG (YPSN.SW) trades on the Swiss Exchange.
What sector is YPSN.SW in?
Ypsomed Holding AG (YPSN.SW) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Ypsomed Holding AG?
Simon Michel is the chief executive officer of Ypsomed Holding AG (YPSN.SW).
Where is Ypsomed Holding AG headquartered?
Ypsomed Holding AG is headquartered in Switzerland.
Does YPSN.SW pay a dividend?
Yes — Ypsomed Holding AG (YPSN.SW) paid a trailing twelve-month dividend of CHF 2.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did YPSN.SW go public?
Ypsomed Holding AG (YPSN.SW) completed its initial public offering in 2004.